Importing oncology trials from China: a bridge over troubled waters?
Authors:
- 4 February 2022
- journal article
- editorial
- Published by Elsevier in The Lancet Oncology
- Vol. 23 (3) , 323-325
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Promoting Inclusion of Members of Racial and Ethnic Minority Groups in Cancer Drug DevelopmentJAMA Oncology, 2021
- Project Orbis: Global Collaborative Review ProgramClinical Cancer Research, 2020
- Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11)Journal of Thoracic Oncology, 2020